Document is current
Any future updates will be listed below
-
Authors
Strobel, Katie M. https://orcid.org/0000-0002-7717-0425
Kafali, Sevgi Gokce
Shih, Shu-Fu
Artura, Alexandra M. https://orcid.org/0000-0001-6322-1554
Masamed, Rinat
Elashoff, David
Wu, Holden H. https://orcid.org/0000-0002-2585-5916
Calkins, Kara L. https://orcid.org/0000-0001-6658-7981
-
Funding
Funding for this research was provided by:
University of California Los Angeles Children's Discovery and Innovation Institute, Department of Pediatrics
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01-124417-01, R01-124417-01)
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- License Information
-
More Information
Article History
Received: 16 July 2022
Revised: 19 October 2022
Accepted: 20 October 2022
First Online: 1 November 2022
Competing interests
: KLC has received research support from Fresenius Kabi. KLC has served as an advisor for Fresenius Kabi, Mead Johnson, Baxter, and Prolacta. KLC serves as an institutional principal investigator, with no salary funding, for a consortium database sponsored by Mead Johnson. HHW receives research support from Siemens Medical Solutions USA.
: The University of California Los Angeles Institutional review board approved the study. Each participant participated with informed consent. The study was performed in accordance with Declaration of Helsinki.
